Skip to main content

Table 2 Inpatients characteristics and medical expenses

From: Evaluation of the effectiveness of comprehensive drug price reform: a case study from Shihezi city in Western China

Indicators

Overall (N = 238,620)

Pre-CDPR period (n = 123,980)

Post-CDPR period (n = 114,640)

Age (years)

 Median (IQR)

61.0 (49–74)

60.0 (48–74)

62.0 (49–75)

 ≥ 65

104,580 (43.8)

52,956 (42.7)

51,624 (45.0)

 < 65

134,040 (56.2)

71,024 (57.3)

63,016 (55.0)

Gender

 Female

130,061 (54.5)

67,461 (54.4)

62,600 (54.6)

 Male

108,559 (45.5)

56,519 (45.6)

52,040 (45.4)

Medical Institution

 Primary hospital

111,658 (46.8)

53,331 (43.0)

58,327 (50.9)

 Secondary hospital

50,955 (21.4)

29,192 (23.5)

21,763 (19.0)

 Tertiary hospital

76,007 (31.9)

41,457 (33.4)

34,550 (30.1)

BMI

 UEMI

185,774 (77.9)

96,630 (77.9)

89,144 (77.8)

 URRMI

52,846 (22.1)

27,350 (22.1)

25,496 (22.2)

  1. Data are n (%). Abbreviation: CDPR comprehensive drug price reform, IQR interquartile range, UEMI urban employee medical insurance, URRMI urban and rural resident medical insurance